Listed

Standard Biotools Inc.: Form 10-Q for the period ended Jun 30, 2014

Filed with the SEC on Aug 4, 2014 and accepted by EDGAR at Aug 4, 2014, 15:57 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-04-01 to 2014-06-30$27.6mus-gaap:Revenues
Revenue6 months2014-01-01 to 2014-06-30$53.3mus-gaap:Revenues
Cost of revenue3 months2014-04-01 to 2014-06-30$10.0mus-gaap:CostOfGoodsSold
Cost of revenue6 months2014-01-01 to 2014-06-30$18.7mus-gaap:CostOfGoodsSold
Research and development3 months2014-04-01 to 2014-06-30$11.4mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2014-01-01 to 2014-06-30$19.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2014-04-01 to 2014-06-30$18.7mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2014-01-01 to 2014-06-30$33.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2014-04-01 to 2014-06-30−$12.4mus-gaap:OperatingIncomeLoss
Operating income6 months2014-01-01 to 2014-06-30−$29.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2014-04-01 to 2014-06-30$1.4mus-gaap:InterestExpense
Interest expense6 months2014-01-01 to 2014-06-30$2.4mus-gaap:InterestExpense
Income tax3 months2014-04-01 to 2014-06-30−$1.1mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2014-01-01 to 2014-06-30−$3.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-04-01 to 2014-06-30−$12.7mus-gaap:NetIncomeLoss
Net income6 months2014-01-01 to 2014-06-30−$28.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-04-01 to 2014-06-30−$0.45us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2014-01-01 to 2014-06-30−$1.03us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2014-01-01 to 2014-06-30−$10.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2014-01-01 to 2014-06-30$4.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-06-30$43.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-06-30$127.4mus-gaap:AssetsCurrent
Total assetsAt period end2014-06-30$417.7mus-gaap:Assets
Current liabilitiesAt period end2014-06-30$27.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-06-30$255.9mus-gaap:Liabilities
Shareholders' equityAt period end2014-06-30$161.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001162194-14-000063. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.